Integrin αv and coxsackie adenovirus receptor expression in clinical bladder cancer

被引:111
|
作者
Sachs, MD
Rauen, KA
Ramamurthy, M
Dodson, JL
De Marzo, AM
Putzi, MJ
Schoenberg, MP
Rodriguez, R
机构
[1] Johns Hopkins Univ Hosp, Brady Urol Inst, Baltimore, MD 21287 USA
[2] Humboldt Univ, Charite Med Sch, Dept Urol, Berlin, Germany
[3] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Canc Res Inst, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[5] Johns Hopkins Univ Hosp, Dept Surg Pathol, Johns Hopkins Oncol Ctr, Baltimore, MD 21287 USA
关键词
D O I
10.1016/S0090-4295(02)01748-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To evaluate the expression of the coxsackie and adenovirus receptor (CAR) and alpha(v) integrins in clinical specimens of bladder cancer to determine the susceptibility to adenoviral gene therapy. Efficient adenovirus-based gene therapy requires binding of the virus to CAR and involves the alpha(v) integrins. Studies on bladder cancer cell lines have shown that low adenoviral transduction rates were associated with low-level expression of CAR. Integrin alpha(v) expression increases in various tumors suggest its importance in differentiation, proliferation, and migration. CAR is structurally a member of the Ig-type superfamily of cell-cell adhesion molecules, suggesting that its expression may also be related to the state of tumor differentiation. Methods. We performed immunohistochemistry for CAR and integrin alpha(v) expression in bladder cancer specimens in 50 paraffin-embedded tumor-normal pairs and confirmed the results by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of 11 separate bladder tumors and 4 separate normal bladder controls. Results. Immunochemistry demonstrated a stage and grade-dependent decrease in CAR expression (90.0%, 83.3%, and 31.3% of normal urothelium and superficial and invasive transitional cell carcinoma [TCC] and 83.3% and 39.5% of low and high-grade TCC, respectively). Furthermore, we found a stage and grade-dependent increase in alpha(v) integrin expression (13.3%, 46.0%, and 56.3% of normal urothelium, superficial TCC, and invasive TCC and 25% and 52.6% of low and high-grade TCC, respectively). Quantitative RT-PCR analysis confirmed a downregulation at the CAR gene expression level. Conclusions. This down-regulation may have a major impact on developing adenoviral-based gene therapy modalities. In addition, we propose that loss of CAR expression decreases rigid cell adhesion, possibly increasing the migratory potential. Loss of CAR expression correlates with the invasive phenotype in our analysis of bladder cancer. Simultaneously, the finding of increased alpha(v) expression in invasive cancer suggests a pathogenesis that involves heterophilic adhesion and migration of these cells on various extracellular ligands.
引用
收藏
页码:531 / 536
页数:6
相关论文
共 50 条
  • [1] Evaluating the expression of the coxsackie and adenovirus receptor (CAR) in patients with bladder cancer
    Pong, RC
    Yang, LY
    Okegawa, T
    Saboorian, H
    Lindberg, G
    Sagalowsky, AI
    Hsieh, JT
    JOURNAL OF UROLOGY, 2002, 167 (04): : 111 - 111
  • [2] The Loss Expression of Coxsackie and Adenovirus Receptor Enhances the Feature of Aggressive Bladder Cancer
    Matsumoto, Kazumasa
    Shariat, Sharokh F.
    Irie, Akira
    Fujita, Tetsuo
    Okusa, Hiroshi
    Satoh, Takefumi
    Iwamura, Masatsugu
    Baba, Shiro
    Lerner, Seth P.
    MOLECULAR THERAPY, 2006, 13 : S326 - S326
  • [3] Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer
    Matsumoto, K
    Shariat, SF
    Ayala, GE
    Rauen, KA
    Lerner, SP
    UROLOGY, 2005, 66 (02) : 441 - 446
  • [4] Increased expression of the coxsackie and adenovirus receptor downregulates αvβ3 and αvβ5 integrin expression and reduces cell adhesion and migration
    Majhen, Dragomira
    Stojanovic, Nikolina
    Speljko, Tea
    Brozovic, Anamaria
    De Zan, Tihana
    Osmak, Maja
    Ambriovic-Ristov, Andreja
    LIFE SCIENCES, 2011, 89 (7-8) : 241 - 249
  • [5] Upregulation of coxsackie and adenovirus receptor gene expression by novel chemotherapeutic agents in bladder cancer cells
    Hsieh, JT
    Pong, RC
    Roark, R
    Frenkel, EP
    Sagalowsky, AI
    JOURNAL OF UROLOGY, 2004, 171 (04): : 255 - 255
  • [6] Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells
    Markus D Sachs
    Meera Ramamurthy
    Henk van der Poel
    Thomas J Wickham
    Martine Lamfers
    Winald Gerritsen
    Wasim Chowdhury
    Ying Li
    Mark P Schoenberg
    Ronald Rodriguez
    Cancer Gene Therapy, 2004, 11 : 477 - 486
  • [7] Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells
    Sachs, MD
    Ramamurthy, M
    van der Poel, H
    Wickham, TJ
    Lamfers, M
    Gerritsen, W
    Chowdhury, W
    Li, Y
    Schoenberg, MP
    Rodriguez, R
    CANCER GENE THERAPY, 2004, 11 (07) : 477 - 486
  • [8] Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie-adenovirus receptor and αvβ5 integrin expression
    Richardson, C
    Brennan, P
    Powell, M
    Prince, S
    Chen, YH
    Spiller, OB
    Rowe, M
    JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 1669 - 1679
  • [9] Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application
    Pong, Rey-Chen
    Roark, Ryan
    Ou, Jiun-Yih
    Fan, Jianhai
    Stanfield, Jennifer
    Frenkel, Eugene
    Sagalowsky, Arthur
    Hsieh, Jer-Tsong
    CANCER RESEARCH, 2006, 66 (17) : 8822 - 8828
  • [10] The inhibition of cyclooxygenase-2 (COX-2) expression by coxsackie and adenovirus receptor (CAR) in bladder cancer
    Hsieh, JT
    Yang, LY
    Pong, RC
    Saboorian, H
    Sagalowsky, AI
    JOURNAL OF UROLOGY, 2003, 169 (04): : 186 - 186